OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Functional brain architecture is associated with the rate of tau accumulation in Alzheimer’s disease
Nicolai Franzmeier, Julia Neitzel, Anna Rubinski, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 257

Showing 1-25 of 257 citing articles:

Alzheimer's disease
Philip Scheltens, Bart De Strooper, Miia Kivipelto, et al.
The Lancet (2021) Vol. 397, Iss. 10284, pp. 1577-1590
Open Access | Times Cited: 2963

Alzheimer disease
David S. Knopman, Hélène Amieva, Ronald C. Petersen, et al.
Nature Reviews Disease Primers (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 1476

Biomarkers for neurodegenerative diseases
Oskar Hansson
Nature Medicine (2021) Vol. 27, Iss. 6, pp. 954-963
Open Access | Times Cited: 717

The human connectome in Alzheimer disease — relationship to biomarkers and genetics
Meichen Yu, Olaf Sporns, Andrew J. Saykin
Nature Reviews Neurology (2021) Vol. 17, Iss. 9, pp. 545-563
Open Access | Times Cited: 172

Emerging roles of innate and adaptive immunity in Alzheimer’s disease
Xiaoying Chen, David M. Holtzman
Immunity (2022) Vol. 55, Iss. 12, pp. 2236-2254
Open Access | Times Cited: 161

Neuropathological evidence of body-first vs. brain-first Lewy body disease
Per Borghammer, Jacob Horsager, Katrine B. Andersen, et al.
Neurobiology of Disease (2021) Vol. 161, pp. 105557-105557
Open Access | Times Cited: 139

ADAMANT: a placebo-controlled randomized phase 2 study of AADvac1, an active immunotherapy against pathological tau in Alzheimer’s disease
Petr Novák, Branislav Kováčech, Stanislav Katina, et al.
Nature Aging (2021) Vol. 1, Iss. 6, pp. 521-534
Closed Access | Times Cited: 121

Regional Aβ-tau interactions promote onset and acceleration of Alzheimer’s disease tau spreading
Wha Jin Lee, Jesse A. Brown, Hye Ryun Kim, et al.
Neuron (2022) Vol. 110, Iss. 12, pp. 1932-1943.e5
Open Access | Times Cited: 120

Asymmetric thinning of the cerebral cortex across the adult lifespan is accelerated in Alzheimer’s disease
James M. Roe, Dídac Vidal-Piñeiro, Øystein Sørensen, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 117

Using the Alzheimer's Disease Neuroimaging Initiative to improve early detection, diagnosis, and treatment of Alzheimer's disease
Dallas P. Veitch, Michael W. Weiner, Paul Aisen, et al.
Alzheimer s & Dementia (2021) Vol. 18, Iss. 4, pp. 824-857
Open Access | Times Cited: 108

Intrinsic connectivity reveals functionally distinct cortico-hippocampal networks in the human brain
Alexander J. Barnett, Walter Reilly, Halle R. Dimsdale-Zucker, et al.
PLoS Biology (2021) Vol. 19, Iss. 6, pp. e3001275-e3001275
Open Access | Times Cited: 104

Synaptic oligomeric tau in Alzheimer’s disease — A potential culprit in the spread of tau pathology through the brain
Martí Colom‐Cadena, C. T. M. Davies, Sònia Sirisi, et al.
Neuron (2023) Vol. 111, Iss. 14, pp. 2170-2183.e6
Open Access | Times Cited: 97

Amyloid-associated increases in soluble tau relate to tau aggregation rates and cognitive decline in early Alzheimer’s disease
Alexa Pichet Binette, Nicolai Franzmeier, Nicola Spotorno, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 84

Tau deposition patterns are associated with functional connectivity in primary tauopathies
Nicolai Franzmeier, Matthias Brendel, Leonie Beyer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 72

Connectome-based modelling of neurodegenerative diseases: towards precision medicine and mechanistic insight
Jacob W. Vogel, Nick Corriveau‐Lecavalier, Nicolai Franzmeier, et al.
Nature reviews. Neuroscience (2023) Vol. 24, Iss. 10, pp. 620-639
Closed Access | Times Cited: 72

The foundation and architecture of precision medicine in neurology and psychiatry
Harald Hampel, Peng Gao, Jeffrey L. Cummings, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 3, pp. 176-198
Open Access | Times Cited: 67

The brain-first vs. body-first model of Parkinson’s disease with comparison to alternative models
Per Borghammer
Journal of Neural Transmission (2023) Vol. 130, Iss. 6, pp. 737-753
Closed Access | Times Cited: 51

Data-driven modelling of neurodegenerative disease progression: thinking outside the black box
Alexandra L. Young, Neil P. Oxtoby, Sara Garbarino, et al.
Nature reviews. Neuroscience (2024) Vol. 25, Iss. 2, pp. 111-130
Closed Access | Times Cited: 27

Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
Nicolai Franzmeier, Amir Dehsarvi, Anna Steward, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 21

Amyloid-associated hyperconnectivity drives tau spread across connected brain regions in Alzheimer’s disease
Sebastian Niclas Roemer, Franziska Wagner, Lisa Evangelista, et al.
Science Translational Medicine (2025) Vol. 17, Iss. 782
Closed Access | Times Cited: 3

Tipping the Scales: Peptide-Dependent Dysregulation of Neural Circuit Dynamics in Alzheimer’s Disease
Sam Harris, Fred Wolf, Bart De Strooper, et al.
Neuron (2020) Vol. 107, Iss. 3, pp. 417-435
Open Access | Times Cited: 136

Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer’s disease
Nicolai Franzmeier, Anna Dewenter, Lukas Frontzkowski, et al.
Science Advances (2020) Vol. 6, Iss. 48
Open Access | Times Cited: 129

Cell-to-Cell Transmission of Tau and α-Synuclein
Norihito Uemura, Maiko Uemura, Kelvin C. Luk, et al.
Trends in Molecular Medicine (2020) Vol. 26, Iss. 10, pp. 936-952
Open Access | Times Cited: 116

Tau-PET and in vivo Braak-staging as prognostic markers of future cognitive decline in cognitively normal to demented individuals
Davina Biel, Matthias Brendel, Anna Rubinski, et al.
Alzheimer s Research & Therapy (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 99

Page 1 - Next Page

Scroll to top